Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity

CONCLUSION: While there were geometric differences between the MDU and SUM, there was no clinically significant difference between urethral dose-volume parameters. This surrogate model could be validated in a larger cohort and then used to estimate the urethral dose on CT planning scans in those without an MRI planning scan or urinary catheter.PMID:38586079 | PMC:PMC10998036 | DOI:10.1016/j.ctro.2024.100769

Source: Clinical Prostate Cancer - April 8, 2024 Category: Cancer & Oncology Authors: Ragu Ratnakumaran Jonathan Mohajer Samuel J Withey Douglas H Brand Ernest Lee Andrew Loblaw Shaun Tolan Nicholas van As Alison C Tree PACE Trial Investigators Source Type: research